The Australian Injecting and Illicit Drug Users League (AIVL), in partnership with The ID Crowd and Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM), announce the release of a new online training module designed to enhance communication and understanding between people who use drugs and healthcare professionals.
A community brief on U=U (Undetectable = Untransmissible) drafted by the International Council of AIDS Services Organisations (ICASO) based out of Toronto, Canada in partnership with several Canadian organisations has been launched at the annual Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM) conference currently being held in Canberra, Australia.
Please note that this blog post is correct as at October 10, 2017. For general information about access to PrEP on the PBS, please click here.
The ACT PrEP trial has commenced, and the ACT Government is providing more than $110,000 to support the local trial, which will include up to 315 participants over 15 months. The trial is being conducted through the Canberra Sexual Health Centre at Canberra Hospital and the Interchange General Practice in Civic.
The local trial is part of the Expanded Pre-Exposure Prophylaxis Implementation in Communities in NSW Trial (EPIC-NSW trial) funded by NSW Health and run by the Kirby Institute at the University of New South Wales.
The AIDS Action Council is partnering with Green Cross Pharmacy Australia to improve access to PrEP for our communities. Through our relationship with Green Cross Pharmacy, the AIDS Action Council is able to assist you in accessing PrEP for free. Find out more about this program by clicking the link below.
Transgender women living with HIV may be hesitant to use antiretroviral therapy (ART) or not take it as prescribed because of concerns about drug interactions with feminising hormones, according to a presentation at the 9th International AIDS Society Conference on HIV Science (IAS 2017) last month in Paris.